Reliability and validity of 5 databases for the identification of warfarin-medication interactions

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 6, 2011, Pages

  Kornblith, Aaron ^a,b   Heard, Kennon ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

Author keywords

anticoagulants; clinical pharmacology; drug interaction

Indexed keywords

AMOXICILLIN; ATENOLOL; ATORVASTATIN; CARBAMAZEPINE; CHLORAMPHENICOL; CIMETIDINE; CLOPIDOGREL; ERYTHROMYCIN; FLUINDOSTATIN; FLUOXETINE; IBUPROFEN; ISONIAZID; KETOCONAZOLE; LEVOFLOXACIN; METOPROLOL; METRONIDAZOLE; MEVINOLIN; NAPROXEN; OMEPRAZOLE; PHENYTOIN; PROPRANOLOL; RANITIDINE; RIFAMPICIN; TETRACYCLINE; TETRAHYDROLIPSTATIN; TICLOPIDINE; TRAMADOL; TRAZODONE; UNINDEXED DRUG; WARFARIN;

ARTICLE; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; PRIORITY JOURNAL; REFERENCE DATABASE; RELIABILITY; SYSTEMATIC REVIEW; VALIDITY;

ANTICOAGULANTS; DATABASES, FACTUAL; DRUG INTERACTIONS; HUMANS; REPRODUCIBILITY OF RESULTS; WARFARIN;

EID: 84857206937     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029610385673     Document Type: Article

References (9)

1. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005 ; 165 (10). 1095-1106 (Pubitemid 40720733)
2. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996 ; 348 (9025). 423-428 (Pubitemid 26267872)
3. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briët E.. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995 ; 333 (1). 11-17
4. Aparasu R, Baer R, Aparasu A.. Clinically important potential drug-drug interactions in outpatient settings. Res Social Adm Pharm. 2007 ; 3 (4). 426-437
5. Feldstein AC, Smith DH, Perrin N, et al. Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med. 2006 ; 166 (9). 1009-1015
6. Langdorf MI, Fox JC, Marwah RS, Montague BJ, Hart MM.. Physician versus computer knowledge of potential drug interactions in the emergency department. Acad Emerg Med. 2000 ; 7 (11). 1321-1329
7. Schalekamp T, Klungel OH, Souverein PC, de Boer A.. Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med. 2008 ; 168 (2). 180-185 (Pubitemid 351185885)
8. Smith AG.. Potentiation of oral anticoagulants by ketoconazole. Br Med J (Clin Res Ed). 1984 ; 288 (6412). 188-189 (Pubitemid 14075735)
9. Brass C, Galgiani JN, Blaschke TF, Defelice R, O'Reilly RA, Stevens DA.. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother. 1982 ; 21 (1). 151-158 (Pubitemid 12189489)